FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma.

Cancer Imaging · 2015 · PMC4558962 · PMID 26335224

Europe PMC DOI

hedged sentence

0.0450

closest p · 0.9× alpha

0.0450

boldest claim

The sentences

a significant trendp = 0.045actually significant

This effect was confirmed as a significant trend in metabolic response with increasing weeks of treatment (cohorts) (likelihood ratio chi-square = 4.00, p = 0.045).

also in 6,248 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.